New clinical findings show Optavia’s Optimal Weight 5 & 1 Plan preserved 98% of lean mass over 16 weeks, underscoring its focus on metabolic health beyond weight loss. The company positions its ...

Allied Market Research published a report titled," Weight Management Market Size was valued at USD 144.6 billion in 2023 and ...

Medifast (NYSE:MED) reported first-quarter 2026 results that management characterized as an early step toward stabilizing the ...

According to Research and Markets, the global health coaching market is projected to grow in value from $20.53 billion in ...

Wellness company Medifast (NYSE:MED) reported Q1 CY2026 results exceeding the market’s revenue expectations, but sales fell ...

Demand for weight loss drugs is ballooning across the U.S. — and Amazon wants in. The Seattle-based tech giant launched its own GLP-1 program aimed at streamlining access to weight loss drugs, with ...

Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It's a ...

Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

Side effects like nausea, vomiting, diarrhea and constipation are common soon after starting GLP-1s or increasing the drug’s dosage. A nutrient-dense diet and regular exercise a ...

Amazon One Medical launched a GLP-1 program integrating obesity care with Amazon Pharmacy. Pricing for the popular weight loss drugs will begin at as low as $25 per month with insurance. Shares of ...